14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 IGMS stock ended at $9.93. This is 1.00% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 4.43% from a day low at $9.83 to a day high of $10.27.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical IGM Biosciences, Inc. prices

Date Open High Low Close Volume
May 07, 2024 $10.02 $10.27 $9.83 $9.93 263 068
May 06, 2024 $9.85 $10.31 $9.64 $10.03 163 375
May 03, 2024 $9.73 $10.19 $9.72 $10.07 181 785
May 02, 2024 $9.67 $9.67 $9.09 $9.43 189 460
May 01, 2024 $9.63 $10.18 $9.38 $9.48 187 893
Apr 30, 2024 $9.50 $9.86 $9.16 $9.63 238 907
Apr 29, 2024 $9.46 $10.46 $9.40 $9.70 599 162
Apr 26, 2024 $7.74 $9.48 $7.41 $9.40 467 408
Apr 25, 2024 $7.76 $7.76 $6.39 $7.65 546 337
Apr 24, 2024 $7.76 $8.60 $7.75 $7.96 692 933
Apr 23, 2024 $6.79 $7.85 $6.79 $7.70 413 494
Apr 22, 2024 $7.25 $7.25 $6.70 $6.75 237 878
Apr 19, 2024 $7.35 $7.43 $7.04 $7.20 219 336
Apr 18, 2024 $8.01 $8.27 $7.12 $7.41 446 866
Apr 17, 2024 $9.37 $9.37 $8.05 $8.13 252 197
Apr 16, 2024 $9.18 $9.56 $8.99 $9.20 140 228
Apr 15, 2024 $9.14 $9.79 $8.93 $9.41 185 106
Apr 12, 2024 $8.32 $9.26 $8.28 $9.16 320 926
Apr 11, 2024 $8.27 $8.41 $8.09 $8.36 232 692
Apr 10, 2024 $8.74 $8.74 $7.93 $8.18 237 573
Apr 09, 2024 $8.81 $9.07 $8.64 $8.74 170 428
Apr 08, 2024 $8.86 $9.14 $8.61 $8.76 125 284
Apr 05, 2024 $8.75 $9.11 $8.59 $8.76 98 416
Apr 04, 2024 $9.21 $9.52 $8.86 $8.89 124 503
Apr 03, 2024 $9.33 $9.33 $8.66 $9.03 137 827
Click to get the best stock tips daily for free!

About IGM Biosciences, Inc.

IGM Biosciences. IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinica... IGMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT